Extracellular matrix-regulated p53 expression and nuclear localization in cultured Detroit 562 cells derived from pharyngeal carcinoma

Archives of Histology and Cytology

Volumn 66, Issue 5, 2003, Pages 419-428

  Li, Li Na ^a   Wang, Da Ren ^a   Sato, Mitsuru ^a   Kojima, Naosuke ^a   Imai, Katsuyuki ^a   Higashi, Nobuyo ^a   Senoo, Haruki ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CELL NUCLEUS ANTIGEN; COLLAGEN TYPE 1; MATRIGEL; POLYSTYRENE; PROTEIN P53; TRANSCRIPTION FACTOR;

ARTICLE; BASEMENT MEMBRANE; CELL PROLIFERATION; CONTROLLED STUDY; DNA BINDING; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; NICK END LABELING; PHARYNX CARCINOMA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; WESTERN BLOTTING;

BIOCOMPATIBLE MATERIALS; BLOTTING, WESTERN; BROMODEOXYURIDINE; CARCINOMA; CELL LINE, TUMOR; CELL NUCLEUS; COLLAGEN; DRUG COMBINATIONS; EXTRACELLULAR MATRIX; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IN SITU NICK-END LABELING; LAMININ; PHARYNGEAL NEOPLASMS; POLYSTYRENES; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEOGLYCANS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 1642463907     PISSN: 09149465     EISSN: None     Source Type: Journal    
DOI: 10.1679/aohc.66.419     Document Type: Article

References (38)

1. Bosari S, Viale G, Roncalli M, Graziani D, Borsani G, Lee AK, Coggi G: p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma. Am J Pathol 147: 790-798 (1995).
2. Boyd SD, Tsai KY, Jacks T: An intact HDM2 RING-finger domain is required for nuclear exclusion of p53. Nature Cell Biol 2: 563-568 (2000).
3. Brooks CL, Gu W: Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Current Opin Cell Biol 15: 164-171 (2003)
4. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW, Vogelstein B: Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282: 1497-1501 (1998).
5. Chen F, Chang D, Goh M, Klibanov SA, Ljungman M: Role of p53 in cell cycle regulation and apoptosis following exposure to proteasome inhibitors. Cell Growth Differ 11: 239-246 (2000).
6. Debnath J, Mills KR, Collins NL, Reginato MJ, Muthuswamy SK, Brugge JS: The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell 111: 29-40 (2002).
7. Dulic V, Kaufmann WK, Wilson SJ, Tlsty TD, Lees E, Harper JW, Elledge SJ, Reed SI: P53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76: 1013-1023 (1994).
8. Fabbro M, Henderson BR: Regulation of tumor suppressors by nuclear-cytoplasmic shuttling. Exp Cell Res 282: 59-69 (2003).
9. Freedman DA, Wu L, Levine AJ: Functions of the MDM2 oncoprotein. Cell Mol Life Sci 55: 96-107 (1999).
10. Frisch SM, Francis H: Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 124: 619-626 (1994).
11. Fritsche M, Haessler C, Brandner G: Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene 8: 307-318 (1993).
12. Geyer RK, Yu ZK, Maki CG: The MDM2 RING-finger domain is required to promote p53 nuclear export. Nature Cell Biol 2: 569-573 (2000).
13. Giaccia AJ, Kastan MB: The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev 12: 2973-2983 (1998).
14. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 100: 57-70 (2000).
15. Hood JK, Silver PA: Diverse nuclear transport pathways regulate cell proliferation and oncogenesis. Biochem Biophys Acta 147: M31-M41 (2000).
16. Hupp TR, Meek DW, Midgley CA, Lane DP: Regulation of the specific DNA binding function of p53. Cell 71: 875-886 (1992).
17. Hwang BJ, Ford JM, Hanawalt PC, Chu G: Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair. Proc Natl Acad Sci USA 96: 424-428 (1999).
18. Ilic D, Almeida EA, Schlaepfer DD, Dazin P, Aizawa S, Damsky CH: Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis. J Cell Biol 143: 547-560 (1998).
19. Jackson-Grusby L: Modeling cancer in mice. Oncogene 21: 5504-5514 (2002).
20. Jayaraman L, Prives C: Covalent and noncovalent modifiers of the p53 protein. Cell Mol Life Sci 55: 76-87 (1999).
21. Kim WH, Schnaper HW, Nomizu M, Yamada Y, Kleinman HK: Apoptosis in human fibrosarcoma cells is induced by a multimeric synthetic Tyr-Ile-Gly-Ser-Arg (YIGSR)-containing polypeptide from laminin. Cancer Res 54: 5005-5010 (1994).
22. Klibanov SA, O'Hagan HM, Ljungman M: Accumulation of soluble and nucleolar-associated p53 proteins following cellular stress. J Cell Sci 114 (Pt 10): 1867-1873 (2001).
23. Liang SH, Clarke MF: A bipartite nuclear localization signal is required for p53 nuclear import regulated by a carboxyl-terminal domain. J Biol Chem 274: 32699-32703 (1999).
24. Ljungman M: Dial 9-1-1 for p53: Mechanisms of p53 activation by cellular stress. Neoplasia 2:208-225 (2000).
25. Maki CG, Howley PM: Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation. Mol Cell Biol 17: 355-363 (1997).
26. Maltzman W, Czyzyk L: UV irradiation stimulates levels of p53 cellular antigen in nontransformed mouse cells. Mol Cell Biol 4: 1689-1694 (1984).
27. Miyashita T, Reed JC: Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299 (1995).
28. Moll UM, LaQuaglia M, Benard J, Riou G: Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. Proc Natl Acad Sci USA 92: 4407-4411 (1995).
29. Nakai M, Mundy GR, Williams PJ, Boyce B, Yoneda T: A synthetic antagonist to laminin inhibits the formation of osteolytic metastases by human melanoma cells in nude mice. Cancer Res 52: 5395-5399 (1992).
30. Petersen OW, Ronnov-Jessen L, Howllet AR, Bissel MJ: Interaction with basement membrane serves to rapidly distinguishes growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc Natl Acad Sci USA 89:9064-9068 (1992).
31. Price BD, Calderwood SK: Increased sequence-specific p53-DNA binding activity after DNA damage is attenuated by phorbol esters. Oncogene 8: 3055-3062 (1993).
32. Ruoslahti E, Reed JC: Anchorage dependence, integrins, and apoptosis. Cell 77: 477-478 (1994).
33. Seewaldt VL, Mrozek K, Sigle R: Suppression of p53 function in normal human mammary epithelia cells increases sensitivity to extralellular matrix-induced apoptisis. J Cell Biol 115: 471-486 (2001).
34. Smith ML, Ford JM, Hollander MC, Bortnick RA, Amundson SA, Seo YR, Deng CX, Hanawalt PC, Fornace AJ Jr: P53-mediated DNA repair responses to UV radiation: studies of mouse cells lacking p53, p21, and/or gadd45 genes. Mol Cell Biol 20: 3705-3714 (2000).
35. Strange R, Li F, Saurer S, Burkhardt A, and Friis RR: Apoptotic cell death and tissue remodeling during mouse mammary gland involution. Development 115: 49-58 (1992).
36. Streuli CH, Bailey N, Bissell MJ: Control of mammary epithelial differentiation: basement membrane induces tissue-specific gene expression in the absence of cell-cell interaction and morphological polarity. J Cell Biol 115: 1383-1395 (1991).
37. Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C, Bissell MJ: Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 137: 231-245 (1997).
38. Woods DB, Vousden KH: Regulation of p53 function. Exp Cell Res 264: 56-66 (2001).